News & Events
Updates about Leica Biosystems.
Collaboration to enable large-scale transition from glass slides to digital images for pathology diagnoses across all subspecialties VISTA, Calif.—Oct. 11, 2018— Leica Biosystems the cancer diagnostics leader achieved a major digital pathology milestone in its multiyear collaboration with Leeds…
New from Leica Biosystems, first integrated specimen containment and transport system promises to enhance efficiency and diagnostic confidence. RICHMOND, Ill.— October 2, 2018 — Leica Biosystems, the leader in cancer diagnostics from biopsy to diagnosis, today announced the U.S. launch of MammoPort…
Integrating revolutionary technology from Leica Biosystems offers exceptionally high throughput and consistent staining quality to enhance efficiency and diagnostic confidence. NUSSLOCH, GERMANY, 10 SEPTEMBER, 2018. Leica Biosystems, the cancer diagnostics company, today announced the global launch…
Melbourne, Australia – June 18, 2018 - Simplify your research in cancer biology and discover new approaches to diagnosis with the new BOND RX next generation research stainer by Leica Biosystems. The BOND RX system provides researchers with the ability to design their ideal protocol. With…
Nussloch, Germany,30 May2018. Leica Biosystems announcesthe addition of a new family of Rotary Microtomes to its full line of histology equipment and consumables. The line-up includes the HistoCore BIOCUT, HistoCore MULTICUT and HistoCoreAUTOCUT clinical microtomes. Each instrument provides high…
Description Today, both Industry and Academia are heavily investing in Artificial Intelligence (AI). Machine learning has already proven that it is possible to train computers to try and emulate the performance of humans. AI is currently deployed in other industries; however, histology is a highly…
Register Now for On Demand Abstract: An unmet need in tissue diagnostics is the ability to simultaneously detect three or more markers on a single tissue specimen, i.e. multiplexing. Unlike other immunoassays, i.e. flow cytometry, ELISA and bead assays, which solely quantify the biomarker in a…
VISTA, CA – April 12, 2018 – Leica Biosystems will highlight cutting-edge Aperio Scanners* and Aperio Image Analysis Algorithms* at the AACR meeting in Chicago, April 15-18, 2018. Leica Biosystems mission of “Advancing Cancer Diagnostics, Improving Lives” fully aligns with AACR’s 2018 objective of…
BUFFALO GROVE, ILLINOIS – FEBRUARY 1, 2018 - Building on its legacy of excellence in advanced staining technology and pathology processes, Leica Biosystems today announced the release of a significant update to the highly regarded BOND-III IHC and ISH stainer. The new BOND-III makes it easier for…
by Bruce Morey - Contributing Editoradvancedmanufacturing.org I am endlessly fascinated by how inventive people can be, not only in creating things but also in how they adapt existing technology to their own use. Take the microtome, a device used in clinical pathology labs to slice very thin…